View AMCP comments to the FDA on considerations in demonstrating biosimilar interchangeability with a biologic reference product.
AMCP webinar that provided an overview of AMCP's long-term strategic federal legislative agenda.
AMCP webinar that provided an overview of AMCP's long-term strategic federal legislative agenda.
AMCP webinar that provided an overview of AMCP's long-term strategic federal legislative agenda.
Press Release: DA’s Proposed Guidance That Would Reclassify Insulin as a Biologic
